FDA Inspection 1200622 — Ceph Lifesciences Private Limited

Ceph Lifesciences Private Limited — FEI 3008932049

The FDA completed an inspection of Ceph Lifesciences Private Limited on March 10, 2023 in Tehsil Baddi, Solan. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 7 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
March 10, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tehsil Baddi, Solan (India)

Citations

IDCFRDescription
111121 CFR 211.25(a)Training , Education , Experience overall
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
143421 CFR 211.42(c)(10)(iv)Environmental Monitoring System
143621 CFR 211.42(c)(10)(vi)Equipment to control conditions
145121 CFR 211.113(b)Procedures for sterile drug products
440221 CFR 211.192Written record of investigation incomplete
440621 CFR 211.194(a)(2)Suitability of testing methods verified